1. Generics Bulletin
  2. >>Policy & Regulation
  3. >>Drug Pricing

UK Paracetamol Prices Treble Amid Coronavirus Demand

Pricewatch UK – March 2020

 
• By Dave Wallace

Average UK trade prices for paracetamol more than trebled in March as the coronavirus outbreak took hold, while the antiviral valaciclovir saw an average increase of over 300%.

UK
The coronavirus outbreak had a clear effect on UK generics prices in March • Source: Shutterstock: A Plus Vector

A transformative month for the UK in terms of the progression of the coronavirus outbreak has been reflected in the latest generics pricing data for March, with the average price for paracetamol more than trebling amid a surge in demand, and even steeper average price rises seen for molecules such as the antiviral valaciclovir.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Drug Pricing

More from Policy & Regulation

OGD’s Policy Office Cut To Have ‘Profound’ Impact On New Generic Approvals, Warns Former FDA Head Gottlieb

 
• By Urtė Fultinavičiūtė

The elimination of the policy division at the Office of Generic Drugs, tariffs, the Section 232 investigation, and a new executive order to promote lower drug prices seem to both cause and purport to solve the same problem: supply chain disruption.

Cardinal Looks Ahead To A New Decade For US Biosimilars

 
• By Dave Wallace

In the wake of a report marking 10 years since the first US biosimilar launch, Cardinal Health’s Dracey Poore speaks to Generics Bulletin about the successes seen so far and the obstacles that must be overcome if the market is to thrive in the decade ahead.

Regulatory Recap: UK To Capture £1bn Savings With Framework For Best-Value Biologics

 
• By Urtė Fultinavičiūtė

Generics Bulletin reviews global regulatory developments across the world.